Blood News and Research

RSS

Cocktail of two drugs heals damaged hearts

A cocktail of drugs has been found in trials with animals to heal damaged heart muscle.

10 Oct 2006

Overweight in middle age could mean dementia later in life

To add further fuel to the debate over obesity, researchers in France are saying that being overweight in middle age may indicate a higher risk of dementia later in life.

10 Oct 2006

Lower PSA in obese men could be a warning

Researchers in the U.S. say that obese men have lower levels of a protein used to screen for prostate cancer risk, and doctors should take weight into account when determining a man's risk.

10 Oct 2006

Walnuts better for the heart than olive oil

According to Spanish researchers walnuts might be even better for the arteries than olive oil.

10 Oct 2006

Drinking Cola bad for women's bones

If the latest research is to be believed women who drink cola on a regular basis are putting themselves at an increased risk of developing osteoporosis.

9 Oct 2006

Generic hypertension drug a suspect in 19 deaths in Panama

As a result of a mystery illness that has claimed the lives of 19 people, officials in Panama have withdrawn all stocks of a hypertension drug used by thousands to treat high blood pressure.

9 Oct 2006

Dikshit says Dengue under control

As the number of people affected by the mosquito bourne Dengue Fever rises on a daily basis, a government official in Delhi is saying the situation is under control and the public do not need to panic.

8 Oct 2006

National Eye Institute to finance two-year study comparing effectiveness of treatments for macular degeneration

The National Eye Institute on Thursday said it will finance a two-year study comparing the effectiveness of Genentech's eye treatment Lucentis and cancer drug Avastin for treating wet age-related macular degeneration, the New York Times reports.

8 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006

New York Times examines efforts to obtain FDA approval for Abraxane to treat earlier-stage cancer

The New York Times has examined efforts by the pharmaceutical company Abraxis BioScience to obtain FDA approval for its late-stage breast cancer drug Abraxane as a treatment for earlier-stage breast cancer.

5 Oct 2006

Misconceptions about HIV in Europe

Nearly 50% of people ages 15 years and older living in the European Union continue to have misconceptions about how HIV is transmitted, according to a survey released on Monday by the European Commission, the AP/San Francisco Chronicle reports.

5 Oct 2006

FDA approves FluLaval

The U.S. Food and Drug Administration (FDA) today approved FluLaval, an influenza vaccine to immunize people 18 years of age and older against the disease caused by strains of influenza virus judged likely to cause seasonal flu in the Northern Hemisphere in 2006-2007.

5 Oct 2006